CVS Health (CVS) said Friday that data from its weight management program showed participants lost an average of 15% of their weight.
The data was derived from 265,000 patients participating in the program. They included those using GLP-1 anti-obesity medications, who nearly doubled their pre-program weight loss while working with the program to change their diet and lifestyle, the company said.
"The data are clear: GLP-1 weight-loss drugs work best when combined with nutrition, lifestyle support and proper dosing2," said Michelle Gourdine, chief medical officer at CVS Caremark.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。